Chronic myelogenous leukemia (CML) results from long-term hematopoietic stem cell (LT-HSC) transformation by the BCR-ABL1 oncogene. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.